Economic assessment

celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis

By Andreas Maetzel

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

2002

Publisher

Canadian Coordinating Office for Health Technology Assessment

Language

eng

Pages

Description:

subjects: Cost effectiveness, Chemotherapy, Therapeutic use, Rheumatoid arthritis, Nonsteroidal anti-inflammatory agents, Inhibitors, Rofecoxib, Osteoarthritis, Celecoxib, Cyclooxygenase 2